U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

Antioxidant pills do not prevent metabolic syndrome

Printer-friendly version E-mail this page to a friend

Reuters Health

Friday, September 4, 2009

By Amy Norton

NEW YORK (Reuters Health) - People who want to forestall heart disease and diabetes may do better by choosing antioxidant-rich foods instead of antioxidant supplements, a new study suggests.

Researchers found that among more than 5,200 middle-aged adults, antioxidant supplements had no effect on the risk of developing metabolic syndrome over seven-plus years.

Metabolic syndrome refers to a collection of risk factors for type 2 diabetes, heart disease and stroke -- including high blood pressure, abdominal obesity, low levels of "good" HDL cholesterol, elevated triglycerides and high blood sugar. The condition is diagnosed when a person has at least three of those risk factors.

The current findings, reported in the American Journal of Clinical Nutrition, suggest that taking antioxidants in capsule form may not thwart metabolic syndrome.

On the other hand, men and women who began the study with relatively high blood levels of certain antioxidants -- particularly vitamin C and beta-carotene -- were less likely than those with lower levels to develop metabolic syndrome.

The implication is that even though antioxidant supplements might not cut the risk of metabolic syndrome, antioxidant-rich foods just might, according to the researchers, led by Dr. Sebastien Czernichow of the French national research institute INSERM, in Paris.

Blood levels of vitamin C and beta-carotene are "rather good surrogate markers" of people's fruit and vegetable intake, Czernichow told Reuters Health in an email.

"This reinforces the guidelines for an adequate intake of this food group and goes against the regular use of antioxidant pills," he said.

The study included 5,220 adults with an average age of 49 who were randomly assigned to take either a mix of vitamins C and E, beta- carotene, selenium and zinc in capsule form or inactive placebo capsules.

After an average of 7.5 years, 263 study participants had been diagnosed with metabolic syndrome. There was no significant difference in risk between the supplement and placebo groups.

There were differences, though, when the researchers looked at participants' antioxidant blood levels at the study's outset. The one-third with the highest vitamin C levels had about half the risk of metabolic syndrome as those with the lowest levels.

Similarly, the third with the highest beta-carotene levels had only one-third of the risk of metabolic syndrome as those with the lowest beta-carotene concentrations.

In contrast, higher zinc levels in the blood were linked to an increased risk of metabolic syndrome. It's not clear why this is, but the researchers speculate that high zinc levels might, in some people, reflect heavy consumption of red meat -- one of the prime food sources of the mineral.

Good food sources of vitamin C include citrus fruits, strawberries and cantaloupe, and vegetables such as red peppers, broccoli and tomatoes.

Beta-carotene, which is converted in the body into vitamin A, is found in foods such as carrots and sweet potatoes, and leafy greens like spinach and kale.

SOURCE: American Journal of Clinical Nutrition, August 2009.


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: